NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual Help on the Homefront campaign, a philanthropic effort that provides veterans the chance to win funds to help offset their cost of housing or home improvements. Help on the Homefront debuted in 2024 to raise awareness of the nationwide issue of veteran housing challenges and homelessness. InHouse, a line of cannabis high quality flower, vapes, and gummies, is produced and distributed by leading multi-s ...

Local Veterans in Maryland, Massachusetts, Delaware, and Illinois Can Enter to Win $5,000 to Help Offset the Cost of Housing or Home Improvements through November 30NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual Help on the Homefront campaign, a philanthropic effort that provides veterans the chance to win funds to help offset their cost of housing or home improvements. Help on the Homefront debuted in 2024 to raise awareness of the nationwide issu ...

Core Points - Curaleaf is celebrating the sixth year of its national at-register donation program for Breast Cancer Action Month, partnering with The Baldwin Fund to support breast cancer research [1][2] - The Baldwin Fund has raised over $13 million for breast cancer research and is launching a $50 million campaign to achieve National Cancer Institute designation for the Upstate Cancer Center [2][7] - Curaleaf's initiative allows customers to "Round Up for Research" at checkout, with proceeds going to lifesaving research at Upstate Medical University [1][3] Company Overview - Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, known for its commitment to quality and community [5][6] - The company operates a strong distribution network across Europe, Canada, and Australasia, integrating science and research with cultivation and production [6] - Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF [6] Community Engagement - The partnership with The Baldwin Fund allows Curaleaf to enhance its impact nationwide, uniting customers and communities in the fight against breast cancer [2][3] - Curaleaf recognizes Breast Cancer Action Month as an opportunity to honor those affected by breast cancer and to support research efforts [3][4] - The initiative is available at the majority of Curaleaf's retail locations across 13 states, including Arizona, Connecticut, Florida, and New York [4]

Company draws US $50,000,000 to retire US $50,000,000 of its existing senior secured credit facility CHICAGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the closing of a credit agreement agented by Chicago Atlantic Admin, LLC, with participation from a regional bank, to provide the Company a revolving credit facility (the “Revolver”) of US $75,000,000. Upon closing the Revolver, t ...

We recently published 10 Stocks With 10-60% Upside. Tilray Brands Inc. (NASDAQ:TLRY) is one of the top performers on Monday. Tilray soared at an all-time high on Monday as investors took path from President Donald Trump’s promotion of the use of cannabis and cannabidiol (CBD) in the US. In intra-day trading, Tilray Brands Inc. (NASDAQ:TLRY) hit its highest price of $1.86 before trimming gains to finish the day just up by 60.87 percent at $1.85 apiece, as investors took Trump’s three-minute video post pro ...

After President Donald Trump posted a video on one of his social media channels in which he presented CBD as an alternative to existing senior healthcare , some cannabis stocksMy primary area of concentration will be on identifying companies of exceptional caliber, with a proven ability to reinvest capital for impressive returns. Targeting those with a market capitalization of less than $10 billion, affords ample opportunities for growth. The ideal scenario is for these companies to demonstrate a long-term ...

Key Points President Trump posted a pro-marijuana video on Truth Social yesterday. Curaleaf stock promptly leapt 37%. The stock's giving back some gains today, but still looks expensive. 10 stocks we like better than Curaleaf › Curaleaf Holdings (OTC: CURLF) stock, an over-the-counter traded, Stamford, Conn.-based cannabis company, tumbled 5.9% through 11:40 a.m. ET Tuesday after soaring 37% on Monday. I don't think investors need to worry too much about the retreat, however. It looks to me a lot ...

Cannabis stocks have been on an absolute tear in the past month as investors are optimistic that marijuana will soon be legalized at the federal level in the U.S. Curaleaf (CURLF) stock has surged nearly 90% year-to-date, making it the top performer among pot stocks tracked by Barchart. The rally intensified on Monday after President Trump suggested marijuana reclassification could happen within weeks and praised CBD's potential for senior healthcare. The broader market responded enthusiastically, with th ...

Key Points President Trump posted a video yesterday touting the benefits of medical marijuana. The video also urged Medicare coverage of the drug. Green Thumb stock spiked on the news yesterday and today -- but remains cheap. 10 stocks we like better than Green Thumb Industries › Green Thumb Industries (OTC: GTBIF) stock, an over-the-counter traded, Chicago-based cannabis company, jumped more than 5% in early trading Tuesday before giving back most of its profits, and retreating to a 1% gain as of ...

Core Viewpoint - Aurora Cannabis (ACB) shares surged over 28% following President Trump's endorsement of cannabidiol (CBD) as a viable alternative to prescription drugs, highlighting its potential to transform senior healthcare and reduce costs [1]. Group 1: Stock Performance - Following the endorsement, ACB stock is up approximately 68% from its year-to-date low [2]. - Options data indicates a potential price range for ACB shares between $3.94 and $7.52, with near-term expectations suggesting a 16.9% move between $4.76 and $6.70 [5]. Group 2: Regulatory Environment - The stock price rally reflects optimism regarding a potential federal policy shift, particularly the rescheduling of marijuana from Schedule I to Schedule III, which could alleviate financial challenges for cannabis firms [3]. - Aurora Cannabis derives about two-thirds of its revenue from medical channels, positioning it well to benefit from favorable regulatory changes in the medical cannabis sector [4]. Group 3: Market Opportunities - The U.S. medical cannabis market is projected to exceed $15 billion in revenue this year, presenting significant growth opportunities for Aurora Cannabis [4]. Group 4: Financial Challenges - Despite the positive market sentiment, Aurora Cannabis faces ongoing financial difficulties, including persistent cash burn that hampers its path to profitability [6]. - The recent surge in ACB shares has led to concerns that they may no longer be undervalued, suggesting a cautious approach for investors [7].